These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23863188)

  • 21. Health technology assessment and evidence-based policy making: Queensland Department of Health experience.
    Ju H; Hewson K
    Int J Technol Assess Health Care; 2014 Dec; 30(6):595-600. PubMed ID: 25816825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion.
    Diaby V; Goeree R; Hoch J; Siebert U
    Expert Rev Pharmacoecon Outcomes Res; 2015 Feb; 15(1):13-9. PubMed ID: 25267699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complexity and conundrums. Citizens' evaluations of potentially contentious novel food technologies using a deliberative discourse approach.
    Greehy GM; McCarthy MB; Henchion MM; Dillon EJ; McCarthy SN
    Appetite; 2013 Nov; 70():37-46. PubMed ID: 23811347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy.
    Denburg AE; Giacomini M; Ungar W; Abelson J
    Int J Health Policy Manag; 2022 Mar; 11(3):374-382. PubMed ID: 32801223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes.
    Street J; Stafinski T; Lopes E; Menon D
    Int J Technol Assess Health Care; 2020 Apr; 36(2):87-95. PubMed ID: 32151290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citizens' juries in planning research priorities: process, engagement and outcome.
    Gooberman-Hill R; Horwood J; Calnan M
    Health Expect; 2008 Sep; 11(3):272-81. PubMed ID: 18816323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'I just want to be able to make a choice': Results from citizen deliberations about mammography screening in Ontario, Canada.
    Abelson J; Tripp L; Sussman J
    Health Policy; 2018 Dec; 122(12):1364-1371. PubMed ID: 30297301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Priority setting for health technology assessment at CADTH.
    Husereau D; Boucher M; Noorani H
    Int J Technol Assess Health Care; 2010 Jul; 26(3):341-7. PubMed ID: 20584365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A citizens' jury on regulation of McDonald's products and operations in Australia in response to a corporate health impact assessment.
    Anaf J; Baum F; Fisher M
    Aust N Z J Public Health; 2018 Apr; 42(2):133-139. PubMed ID: 29384238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Science and deliberation].
    Ravazzi S
    Epidemiol Prev; 2008; 32(6):319-24. PubMed ID: 19353967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to introduce more (or better) ethical arguments in HTA?
    Schokkaert E
    Int J Technol Assess Health Care; 2015 Jan; 31(3):111-2. PubMed ID: 26044817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Canuto Santos V; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Value Health; 2022 Jun; 25(6):869-886. PubMed ID: 35667778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.
    Abelson J; Wagner F; DeJean D; Boesveld S; Gauvin FP; Bean S; Axler R; Petersen S; Baidoobonso S; Pron G; Giacomini M; Lavis J
    Int J Technol Assess Health Care; 2016 Jan; 32(4):256-264. PubMed ID: 27670693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of patient and public participation in health technology assessment and coverage decisions.
    Menon D; Stafinski T
    Expert Rev Pharmacoecon Outcomes Res; 2011 Feb; 11(1):75-89. PubMed ID: 21351860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making recommendations to subsidize new health technologies in Australia: A qualitative study of decision-makers' perspectives on committee processes.
    Sellars M; Carter SM; Lancsar E; Howard K; Coast J
    Health Policy; 2024 Jan; 139():104963. PubMed ID: 38104371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Citizens' Perspectives on Disinvestment from Publicly Funded Pathology Tests: A Deliberative Forum.
    Street JM; Callaghan P; Braunack-Mayer AJ; Hiller JE
    Value Health; 2015 Dec; 18(8):1050-6. PubMed ID: 26686790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Participatory research to enhance vision sharing for Healthy Town initiatives in Japan.
    Takano T; Nakamura K
    Health Promot Int; 2004 Sep; 19(3):299-307. PubMed ID: 15306614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influencing health policy through public deliberation: Lessons learned from two decades of Citizens'/community juries.
    Degeling C; Rychetnik L; Street J; Thomas R; Carter SM
    Soc Sci Med; 2017 Apr; 179():166-171. PubMed ID: 28285232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical Exposure: European Citizens' Perspectives, Trust, and Concerns on Human Biomonitoring Initiatives, Information Needs, and Scientific Results.
    Uhl M; Santos RR; Costa J; Santos O; Virgolino A; Evans DS; Murray C; Mulcahy M; Ubong D; Sepai O; Lobo Vicente J; Leitner M; Benda-Kahri S; Zanini-Freitag D
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33562859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.